Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Czechia Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20043
20052
20064
20073
20083
20101
20131
20142
20161
20171
20181
20212
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated7
Recruiting3
Active, not recruiting1
Suspended1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi9
Boehringer Ingelheim3
Charles University, Czech Republic3
Bristol-Myers Squibb2
Daiichi Sankyo2
Solvay Pharmaceuticals2
Advanz Pharma1
Anthos Therapeutics, Inc.1
AstraZeneca1
Atrial Fibrillation Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation36
Arrhythmias, Cardiac5
Atrial Flutter5
Stroke5
Heart Diseases3
Cardiovascular Diseases2
Embolism2
Acute Coronary Syndrome1
Acute Kidney Injury1
Atherosclerosis1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.